Medisys in Smiths marketing deal

SAFETY syringes and scalpels developer Medisys has clinched a co-marketing partnership deal with medical devices distributor Smiths Group that will realise $1m (£690,000) in cash immediately with further tranches totalling $3.95m.

Smiths will have exclusive rights to distribute these and other Medisys products such as its needleless valve and a safety lancet in North America, Japan and Britain.

Smiths shares rose 7p to 818p in early trade and Medisys added 6 1/4p to 72p.